MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of a healthy immune system to clear the plethora of antigens it encounters incessantly relies on the enormous plasticity displayed by the comprising cell types. Macrophages (MΦ) are crucial member of the mononuclear phagocyte system (MPS) that constantly patrol the peripheral tissues and are actively recruited to the sites of injury and infection. In tissues, infiltrating monocytes replenish MΦ. Under the guidance of the local micro-milieu, MΦ can be activated to acquire specialized functional phenotypes. Similar to T cells, functional polarization of macrophage phenotype viz., inflammatory (M1) and reparative (M2) is proposed. Equipped with diverse Toll-like receptors (TLRs) these cells of the innate arm of immunity recognize and phagocytize antigens and secrete cytokines that activate the adaptive arm of the immune system and perform key roles in wound repair. Dysregulation of MΦ plasticity has been associated with various diseases and infection. MicroRNAs (miRNAs) have emerged as critical regulators of transcriptome output. Their importance in maintaining health, and their contribution toward disease, encompasses virtually all aspects of human biology. Our understanding of miRNA-mediated regulation of MΦ plasticity and polarization can be utilized to modulate functional phenotypes to counter their role in the pathogenesis of numerous disease including cancer, autoimmunity, periodontitis, etc. Here, we provide an overview of current knowledge regarding the role if miRNA in shaping MΦ polarization and plasticity through targeting of various pathways and genes. Identification of miRNA biomarkers of diagnostic/prognostic value and their therapeutic potential by delivery of miRNA mimics or inhibitors to dynamically alter gene expression profiles in vivo is highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 3×
“For example, miR-146a regulates not only TLR4 expression but also the downstream signaling molecules MyD88, IRAK1, and TRAF6 (47, 48).”
BackgroundWightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292 · cited 1×
“Since their discovery in 1993 (1, 2), our knowledge of miRNA expression and its role in health and disease has grown exponentially.”
BackgroundMacrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · cited 1×
“It should be noted that the role of PPARγ in governing MΦ function is not limited to phagocytosis and extends to promoting alternative activation (74), differentiation (75), and lipid metabolism/foam cell formation (76).”
BackgroundLNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite
Hibbs, J. B., Taintor, R. R., & Vavrin, Z. (1987) · Science · doi:10.1126/science.2432665 · Cited by 1,527
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
New microRNAs from mouse and human
LAGOS-QUINTANA, M., RAUHUT, R., MEYER, J., BORKHARDT, A., & TUSCHL, T. (2003) · RNA · doi:10.1261/rna.2146903 · Cited by 909 · cited 1×
“searched for the human orthologs of 31 murine miRNAs and reported that only one of these was absent from the human genome (10).”
BackgroundPonomarev, E. D., Veremeyko, T., Barteneva, N., Krichevsky, A. M., & Weiner, H. L. (2011) · Nature Medicine · doi:10.1038/nm.2266 · Cited by 787 · cited 16×
“For example, alterations in the composition of gut flora through changes in diet or use of antibiotics/probiotics alter the susceptibility of mice to EAE (115).”
BackgroundInfluentialDevelopment of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625 · cited 3×
“In yet another approach, 2′-oxygen and 4′-carbon on ribonucleotide backbone were chemically locked (120).”
BackgroundMacrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607 · cited 1×
“Indeed, MΦ-derived exosomes has been demonstrated to cross blood–brain barriers and deliver brain-derived neurotrophic factor (BDNF) (132).”
BackgroundMicroRNAs as Regulators of Differentiation and Cell Fate Decisions
Ivey, K. N., & Srivastava, D. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.012 · Cited by 449 · cited 1×
“Several excellent reviews have covered miRNA functionality in the context of leukocyte differentiation (3), innate signaling (4), and T helper (Th) cell biology (5).”
BackgroundMacLeod (2008) · Bristol Research (University of Bristol) · doi:10.4049/jimmunol · Cited by 448
Ferrante, C. J., Pinhal-Enfield, G., Elson, G., Cronstein, B. N., Hasko, G., Outram, S., & Leibovich, S. J. (2013) · Inflammation · doi:10.1007/s10753-013-9621-3 · Cited by 375
MicroRNA let-7c Regulates Macrophage Polarization
Banerjee, S., Xie, N., Cui, H., Tan, Z., Yang, S., Icyuz, M., Abraham, E., & Liu, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202496 · Cited by 320 · cited 7×
“Furthermore, in GM-BMM, overexpression of let-7c alone was sufficient to reduce the expression of M1 markers and increase M2 markers.”
BackgroundMethodResultInfluentialInterferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
Su, X., Yu, Y., Zhong, Y., Giannopoulou, E. G., Hu, X., Liu, H., Cross, J. R., Rätsch, G., Rice, C. M., & Ivashkiv, L. B. (2015) · Nature Immunology · doi:10.1038/ni.3205 · Cited by 298
Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278 · cited 1×
“A PubMed search (“microRNA + adenosine + MΦ”) only identified 13 publications; however, the importance of adenosine signaling in not only generating M2 MΦs but also skewing pro-M1 stimuli toward the M2 phenotype (99), suggests that this is an area ripe for miRNA-based study.”
BackgroundRajaram, M. V. S., Ni, B., Morris, J. D., Brooks, M. N., Carlson, T. K., Bakthavachalu, B., Schoenberg, D. R., Torrelles, J. B., & Schlesinger, L. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112660108 · Cited by 269
miR-125a-5p Regulates Differential Activation of Macrophages and Inflammation
Banerjee, S., Cui, H., Xie, N., Tan, Z., Yang, S., Icyuz, M., Thannickal, V. J., Abraham, E., & Liu, G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426866 · Cited by 258 · cited 2×
“let-7c, miR-125a-5p Expression is higher in M-CSF-derived MΦs as compared to GM-CSF derived (19, 20)”
BackgroundResultWang, Z., Brandt, S., Medeiros, A., Wang, S., Wu, H., Dent, A., & Serezani, C. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0115855 · Cited by 169 · cited 2×
“A recent study found that PGE2 decreases miR-21 expression in MΦs and that this contributes to the expression of genes associated with M2 MΦs (96).”
BackgroundVeremeyko, T., Siddiqui, S., Sotnikov, I., Yung, A., & Ponomarev, E. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081774 · Cited by 165 · cited 10×
“miR-124 Upregulated by M2 markers IL-4 and IL-13 (81, 82)”
BackgroundInfluentialmiR-27a regulates inflammatory response of macrophages by targeting IL-10
Xie, N., Cui, H., Banerjee, S., Tan, Z., Salomao, R., Fu, M., Abraham, E., Thannickal, V. J., & Liu, G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400203 · Cited by 128 · cited 1×
“Another miRNA confirmed as a direct regulator of IL-10 is miR-27a (104).”
BackgroundmiR-24, miR-30b, and miR-142-3p Regulate Phagocytosis in Myeloid Inflammatory Cells
Naqvi, A. R., Fordham, J. B., & Nares, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401893 · Cited by 124 · cited 16×
“We have previously reported that enforced expression of miR-24, miR-30b, or miR142-3p in activated MΦs inhibits their production of IL-12(p40) (11, 13).”
BackgroundResultSelf-citationBettencourt, P., Marion, S., Pires, D., Santos, L. F., Lastrucci, C., Carmo, N., Blake, J., Benes, V., Griffiths, G., Neyrolles, O., et al. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00019 · Cited by 84
miR-15a/16 Regulates Macrophage Phagocytosis after Bacterial Infection
Moon, H.-G., Yang, J., Zheng, Y., & Jin, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401372 · Cited by 81
Lin, L., Hou, J., Ma, F., Wang, P., Liu, X., Li, N., Wang, J., Wang, Q., & Cao, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203450 · Cited by 73
miR-24 Regulates Macrophage Polarization and Plasticity
Afsar R. Naqvi, J. B. F., & Nares, S. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000362 · Cited by 65 · cited 1×
“We have studied the capacity of miR-24 to regulate MΦ plasticity in the context of the interaction between the host (MΦ), pathogen (bacteria), and environment (cigarette smoke) (12).”
BackgroundSelf-citationPlasma nitrate concentration in infective gastroenteritis and inflammatory bowel disease
Dykhuizen, R. S., Masson, J., McKnight, G., Mowat, A. N., Smith, C. C., Smith, L. M., & Benjamin, N. (1996) · Gut · doi:10.1136/gut.39.3.393 · Cited by 59 · cited 1×
“Still, this negative in vitro data did not agree with in vivo data identifying elevated NO levels during infection and/or inflammation (37, 38).”
BackgroundNaqvi, A. R., Fordham, J. B., & Nares, S. (2016) · Innate Immunity · doi:10.1177/1753425916661042 · Cited by 29
Self-citation
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Krzyszczyk, P., Schloss, R., Palmer, A., & Berthiaume, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00419 · Cited by 1,546
Implications of macrophage polarization in autoimmunity
Funes, S. C., Rios, M., Escobar‐Vera, J., & Kalergis, A. M. (2018) · Immunology · doi:10.1111/imm.12910 · Cited by 1,005
Choo, Y. W., Kang, M., Kim, H. Y., Han, J., Kang, S., Lee, J.-R., Jeong, G.-J., Kwon, S. P., Song, S. Y., Go, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02446 · Cited by 465
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
Metadata
- Authors
- Self-Fordham, J. B., Naqvi, A. R., Uttamani, J. R., Kulkarni, V., & Nares, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-08-31
- Volume
- 8
- Pages
- 1062-1062
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2753126785
- Cited by
- 140
- References
- 30
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.